NEW YORK (GenomeWeb) – Bionano Genomics and Genoptix today announced an exclusive agreement to codevelop diagnostic assays for selected hematologic oncology indications.

Bionano will contribute its knowledge of genome structure analysis and its Saphyr system, which is designed to accurately visualize the structure of a genome with a simple DNA sample, isolated directly from cancer cells. The platform can detect all major types of structural variants with greater sensitivity than sequence-based methods, according to Bionano.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
14
Sponsored by
Sophia Genetics

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
26
Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.